CHOP Surgeon Holly L. Hedrick, MD Wins Strittmatter Award
Published on

The Philadelphia County Medical Society (PCMS) has awarded CHOP surgeon Holly L. Hedrick, MD the 2023 Strittmatter Award, its most prestigious scientific honor.
Published on
The Philadelphia County Medical Society (PCMS) has awarded CHOP surgeon Holly L. Hedrick, MD the 2023 Strittmatter Award, its most prestigious scientific honor.
Published on
A range of different noninvasive mechanical ventilation supports helped this patient with pulmonary hypoplasia avoid tracheostomy.
Published on
Learn how CHOP’s dedicated CDH team translates research findings into care advances that improve the lives of children with this condition.
Published on
Early recognition, treatment and management of CDH-related pulmonary hypertension is critical. Our team takes an early and aggressive approach to treatment, and our protocols have been extremely successful.
Published on
CHOP's specialized Pulmonary Hypoplasia Program provides ongoing developmental and medical assessments from infancy through adolescence, with the goal of looking beyond short-term surgical survival and providing long-term clinical care to improve quality of life.
Published on
CHOP collaboration with Nestlé Health Science elevates an idea that is a win for families.
Published on
The case of a full-term infant with a prenatal diagnosis of CDH demonstrates the importance of integrating a neonatal surgery team into the N/IICU for the best postnatal outcomes.
Published on
We evaluate hundreds of children from around the world and offer complete care — from evaluation through long-term follow-up — for severe spine and rib cage abnormalities.
Published on
Neonates with congenital diaphragmatic hernia (CDH) often require intensive treatment after birth and have prolonged hospitalizations, and may suffer a variety of complications after discharge. Comprehensive interdisciplinary follow-up care is critical for long-term well being.
Published on
The Pulmonary Hypoplasia Program at The Children’s Hospital of Philadelphia is committed to tracking outcomes of children with pulmonary hypoplasia in an effort to improve understanding and care. A recent review of neurodevelopmental outcomes at 5 years of age found that CDH survivors are at increased risk for developing emotionally reactive and pervasive developmental problems.